Scarica l'app Stockscreener
5.42
2.34%
-0.13
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ARDX Giù?
Forum
Previsione
Precedente Chiudi:
$5.55
Aprire:
$5.52
Volume 24 ore:
3.60M
Relative Volume:
1.03
Capitalizzazione di mercato:
$1.32B
Reddito:
$386.15M
Utile/perdita netta:
$-56.39M
Rapporto P/E:
-23.57
EPS:
-0.23
Flusso di cassa netto:
$-55.19M
1 W Prestazione:
-7.51%
1M Prestazione:
+2.46%
6M Prestazione:
+35.84%
1 anno Prestazione:
+5.86%
Intervallo 1D:
$5.30
$5.595
Intervallo di 1 settimana:
$5.30
$5.985
Portata 52W:
$3.21
$6.78
Ardelyx Inc Stock (ARDX) Company Profile
Nome
Ardelyx Inc
Settore
Industria
Telefono
510-745-7047
Indirizzo
34175 ARDENWOOD BLVD., FREMONT, CA
Confronta ARDX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ARDX
Ardelyx Inc
|
5.42 | 1.35B | 386.15M | -56.39M | -55.19M | -0.23 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Ardelyx Inc Stock (ARDX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-03 | Ripresa | Raymond James | Strong Buy |
| 2025-06-18 | Ripresa | H.C. Wainwright | Buy |
| 2025-05-02 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2025-03-07 | Ripresa | Ladenburg Thalmann | Buy |
| 2025-03-04 | Iniziato | BTIG Research | Buy |
| 2024-11-11 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2024-07-02 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-04-05 | Iniziato | Leerink Partners | Outperform |
| 2023-12-18 | Iniziato | Raymond James | Strong Buy |
| 2023-09-07 | Iniziato | H.C. Wainwright | Buy |
| 2023-08-25 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2023-03-03 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2022-11-17 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2022-05-06 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2021-12-01 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2021-10-14 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2021-07-21 | Downgrade | Jefferies | Buy → Hold |
| 2021-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-07-20 | Downgrade | Wedbush | Outperform → Neutral |
| 2021-03-23 | Iniziato | Wedbush | Outperform |
| 2021-01-06 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-10-20 | Ripresa | Citigroup | Buy |
| 2020-02-18 | Ripresa | Jefferies | Buy |
| 2020-02-12 | Iniziato | Citigroup | Buy |
| 2020-02-10 | Iniziato | Cowen | Outperform |
| 2019-04-08 | Iniziato | Piper Jaffray | Overweight |
| 2018-08-24 | Iniziato | Jefferies | Buy |
| 2018-03-19 | Ripresa | Leerink Partners | Outperform |
| 2017-11-29 | Reiterato | Citigroup | Buy |
| 2017-11-22 | Reiterato | Ladenburg Thalmann | Buy |
| 2017-10-17 | Ripresa | Leerink Partners | Outperform |
| 2016-03-31 | Iniziato | Ladenburg Thalmann | Buy |
| 2016-03-09 | Iniziato | Cantor Fitzgerald | Buy |
| 2016-03-03 | Iniziato | Citigroup | Buy |
Mostra tutto
Ardelyx Inc Borsa (ARDX) Ultime notizie
How Ardelyx Inc. stock reacts to job market dataIndex Update & Proven Capital Preservation Methods - newser.com
Is Ardelyx Inc. (41X) stock ideal for retirement investorsMarket Activity Recap & Technical Analysis for Trade Confirmation - newser.com
Will Ardelyx Inc. stock gain from government policiesJuly 2025 Review & AI Enhanced Trade Execution Alerts - newser.com
How Ardelyx Inc. stock valuations compare to rivalsDollar Strength & Long-Term Capital Growth Strategies - newser.com
Combining machine learning predictions for Ardelyx Inc.July 2025 Outlook & Short-Term Trading Alerts - newser.com
What momentum indicators show for Ardelyx Inc. stockJuly 2025 Drop Watch & Fast Entry High Yield Stock Tips - newser.com
Will Ardelyx Inc. stock deliver shareholder valueQuarterly Profit Report & Risk Controlled Swing Alerts - newser.com
Why institutional investors increase stakes in Ardelyx Inc. (41X) stockPortfolio Gains Report & Daily Growth Stock Investment Tips - newser.com
Is Ardelyx Inc. forming a bottoming baseWeekly Trade Analysis & Accurate Buy Signal Alerts - newser.com
What high frequency data says about Ardelyx Inc.Portfolio Performance Report & Advanced Swing Trade Entry Alerts - newser.com
Why Ardelyx Inc. stock is recommended by analystsPortfolio Update Summary & Proven Capital Preservation Methods - newser.com
ARDX: IBSRELA and XPHOZAH drive growth, with profitability and new pipeline assets expected by 2026 - TradingView
Ardelyx at Jefferies London Healthcare: Strategic Growth and Challenges By Investing.com - Investing.com Canada
Ardelyx (ARDX): Evaluating Valuation After Upward Guidance Following Strong IBSRELA Sales Growth - simplywall.st
Applying big data sentiment scoring on Ardelyx Inc.Trade Risk Summary & Technical Pattern Based Signals - newser.com
Ardelyx Shares Surge After Regulatory Wins But Is the Stock Fully Priced in 2025? - Yahoo Finance
News impact scoring models applied to Ardelyx Inc.Swing Trade & Weekly Top Performers Watchlists - newser.com
Will Ardelyx Inc. (41X) stock keep high P E multiplesJuly 2025 Catalysts & Free High Accuracy Swing Entry Alerts - newser.com
Can Ardelyx’s (ARDX) Updated IBSRELA Outlook Reveal More About Its Long-Term Growth Potential? - Yahoo Finance
A Look at Ardelyx (ARDX) Valuation Following Real-World XPHOZAH Study Results at Kidney Week - Yahoo Finance
Ardelyx Inc Azioni (ARDX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.38%
1.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):